BeyondSpring (BYSI) Notes Payables (2020 - 2021)

BeyondSpring (BYSI) posted Notes Payables of $278000.0 for Q3 2021, little changed sequentially from $278000.0 in Q2 2021.

BeyondSpring (BYSI) Notes Payables (2020 - 2021) Analysis & Trends

BeyondSpring has reported Notes Payables for 2 years, with the latest figure at $278000.0 in Q3 2021.

Quarterly Notes Payables changed N/A year-over-year to $278000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $278000.0 (changed N/A YoY) and the FY2020 annual result came in at $278000.0, changed N/A from the prior year.
Notes Payables held at $278000.0 in Q3 2021 per BYSI's latest filing, from $278000.0 in the prior quarter.
Over five years, Notes Payables peaked at $278000.0 in Q4 2020 and troughed at $278000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.82 Bn	131.97 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.69 Bn	78.70 Bn	3.93 Bn
3	Argenx Se	65.23 Bn	60.05 Bn	1.37 Bn
4	Moderna	60.16 Bn	55.02 Bn	52.00 Mn
5	BeOne Medicines	42.16 Bn	37.07 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.86 Bn	28.55 Bn	992.69 Mn
7	BioNTech SE	28.24 Bn	9.85 Bn	668.28 Mn
8	Insmed	27.53 Bn	26.37 Bn	358.27 Mn
9	Royalty Pharma	27.31 Bn	26.47 Bn	-
10	BeyondSpring	29.59 Mn	29.59 Mn	-

Download Data